Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury

Context: Hypertonic saline (HTS) is a pharmacologic therapy used in patients with severe traumatic brain injuries to decrease intracranial pressure (ICP) associated with cerebral edema. Aims: The purpose of this study was to compare ICP reduction between fixed doses of 23.4% HTS and weight-based dos...

Full description

Bibliographic Details
Main Authors: Kirsten Busey, Jason Ferreira, Petra Aldridge, Marie Crandall, Donald Johnson
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Emergencies, Trauma and Shock
Subjects:
Online Access:http://www.onlinejets.org/article.asp?issn=0974-2700;year=2020;volume=13;issue=4;spage=252;epage=256;aulast=Busey
_version_ 1818598212747919360
author Kirsten Busey
Jason Ferreira
Petra Aldridge
Marie Crandall
Donald Johnson
author_facet Kirsten Busey
Jason Ferreira
Petra Aldridge
Marie Crandall
Donald Johnson
author_sort Kirsten Busey
collection DOAJ
description Context: Hypertonic saline (HTS) is a pharmacologic therapy used in patients with severe traumatic brain injuries to decrease intracranial pressure (ICP) associated with cerebral edema. Aims: The purpose of this study was to compare ICP reduction between fixed doses of 23.4% HTS and weight-based doses. Setting and Design: This was a retrospective study that included adult patients at a level 1 trauma center who had nonpenetrating traumatic brain injury, an ICP monitor, and received at least one dose of 23.4% HTS. Subjects and Methods: Doses were classified as either high weight-based (>0.6 ml/kg), low weight-based (<0.6 ml/kg), or standard fixed dose (30 ml). Only doses given within 5 days post-injury were evaluated. Percent reduction in ICP was compared pre- and post-dose between dosing groups, and each dose was evaluated as a separate episode. Statistical Analysis: The primary and secondary endpoints for the study were analyzed using mixed-model, repeated-measures analysis of covariance. Results: A total of 97 doses of HTS were evaluated. The primary endpoint of ICP reduction showed a 42.5% decrease in ICP after the administration of a high weight-based dose, a 36.7% reduction after a low weight-based dose, and a 31.5% reduction after a fixed dose. There was no significant relationship between dose group and percent change in ICP (P = 0.25). A sub-analysis of doses received within 48 h postinjury found a significant relationship between both dose group and percent change in ICP, and initial ICP and percent change in ICP (P = 0.04, and <0.0001 respectively). Conclusions: Our data did not show a significant difference between fixed- and weight-based doses of 23.4% HTS for ICP reduction.
first_indexed 2024-12-16T12:00:07Z
format Article
id doaj.art-8ea55a03e947418f864f3adc4f8c4928
institution Directory Open Access Journal
issn 0974-2700
language English
last_indexed 2024-12-16T12:00:07Z
publishDate 2020-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Emergencies, Trauma and Shock
spelling doaj.art-8ea55a03e947418f864f3adc4f8c49282022-12-21T22:32:28ZengWolters Kluwer Medknow PublicationsJournal of Emergencies, Trauma and Shock0974-27002020-01-0113425225610.4103/JETS.JETS_66_19Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injuryKirsten BuseyJason FerreiraPetra AldridgeMarie CrandallDonald JohnsonContext: Hypertonic saline (HTS) is a pharmacologic therapy used in patients with severe traumatic brain injuries to decrease intracranial pressure (ICP) associated with cerebral edema. Aims: The purpose of this study was to compare ICP reduction between fixed doses of 23.4% HTS and weight-based doses. Setting and Design: This was a retrospective study that included adult patients at a level 1 trauma center who had nonpenetrating traumatic brain injury, an ICP monitor, and received at least one dose of 23.4% HTS. Subjects and Methods: Doses were classified as either high weight-based (>0.6 ml/kg), low weight-based (<0.6 ml/kg), or standard fixed dose (30 ml). Only doses given within 5 days post-injury were evaluated. Percent reduction in ICP was compared pre- and post-dose between dosing groups, and each dose was evaluated as a separate episode. Statistical Analysis: The primary and secondary endpoints for the study were analyzed using mixed-model, repeated-measures analysis of covariance. Results: A total of 97 doses of HTS were evaluated. The primary endpoint of ICP reduction showed a 42.5% decrease in ICP after the administration of a high weight-based dose, a 36.7% reduction after a low weight-based dose, and a 31.5% reduction after a fixed dose. There was no significant relationship between dose group and percent change in ICP (P = 0.25). A sub-analysis of doses received within 48 h postinjury found a significant relationship between both dose group and percent change in ICP, and initial ICP and percent change in ICP (P = 0.04, and <0.0001 respectively). Conclusions: Our data did not show a significant difference between fixed- and weight-based doses of 23.4% HTS for ICP reduction.http://www.onlinejets.org/article.asp?issn=0974-2700;year=2020;volume=13;issue=4;spage=252;epage=256;aulast=Buseyhypertonic salineintracranial pressuretraumatic brain injury
spellingShingle Kirsten Busey
Jason Ferreira
Petra Aldridge
Marie Crandall
Donald Johnson
Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
Journal of Emergencies, Trauma and Shock
hypertonic saline
intracranial pressure
traumatic brain injury
title Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
title_full Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
title_fullStr Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
title_full_unstemmed Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
title_short Comparison of weight-based dosing versus fixed dosing of 23.4% hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
title_sort comparison of weight based dosing versus fixed dosing of 23 4 hypertonic saline for intracranial pressure reduction in patients with severe traumatic brain injury
topic hypertonic saline
intracranial pressure
traumatic brain injury
url http://www.onlinejets.org/article.asp?issn=0974-2700;year=2020;volume=13;issue=4;spage=252;epage=256;aulast=Busey
work_keys_str_mv AT kirstenbusey comparisonofweightbaseddosingversusfixeddosingof234hypertonicsalineforintracranialpressurereductioninpatientswithseveretraumaticbraininjury
AT jasonferreira comparisonofweightbaseddosingversusfixeddosingof234hypertonicsalineforintracranialpressurereductioninpatientswithseveretraumaticbraininjury
AT petraaldridge comparisonofweightbaseddosingversusfixeddosingof234hypertonicsalineforintracranialpressurereductioninpatientswithseveretraumaticbraininjury
AT mariecrandall comparisonofweightbaseddosingversusfixeddosingof234hypertonicsalineforintracranialpressurereductioninpatientswithseveretraumaticbraininjury
AT donaldjohnson comparisonofweightbaseddosingversusfixeddosingof234hypertonicsalineforintracranialpressurereductioninpatientswithseveretraumaticbraininjury